South and Central America Typhoid Fever Vaccines Market Trends and Analysis by 2027

The South and Central America typhoid fever vaccines  market is expected to reach US$ 24.37 million in 2027 from US$ 13.79 million. The market is estimated to grow with a CAGR of 7.7% from 2020-2027.

The growth of the market is driven by the factors such as, prevalence of typhoid in the region, and poor sanitation facilities. However, risks associated with typhoid fever vaccines is likely to have negative impact on the growth of the South and Central America Typhoid Fever Vaccines market in the coming years.

Typhoid fever is prevalent among the South and Central America (SCAM)n countries where the sanitation, water treatment and waste management is inefficient. Incidence levels of typhoid fever in Brazil has reduced, however, it is still prevalent in the northern part of Brazil. Also, during the investigation of water quality at Olympic venues in 2016 reported high levels of Salmonella typhi contamination at all locations. In Rio, much of the sewage is left untreated and additionally the human faeces and household garbage runs directly into local rivers and beaches. Thus, the presence of high levels of human sewage, and fecal bacteria, indicates the presence of typhoid bacteria in the Rio waterways. Typhoid spreads through fecal-oral transmission, and is contracted through eating and drinking contaminated food and water putting travelers at risk. Thus, CDC recommends typhoid vaccine for those travelling to Brazil.

Thus, the prevalence of typhoid fever in South and Central America (SCAM) countries is likely to have positive impact on typhoid fever vaccines market during the forecast period.  

Furthermore, Latin America is hit by the COVID-19 pandemic and thus has profound humanitarian, economic, and political consequences. South and Central America are among the regions with rising number of reported cases of COVID-19. As per the data of Worldometer, Brazil reported 4,780,317 COVID-19 instances, and Argentina recorded 736,609 counts as of October 06, 2020. Deaths reported in Brazil were 143,010 and in Argentina, the death toll was 16,519. They have responded to the situation by closing borders, ordering quarantines, and imposing a host of restrictions to keep people confined at home. In July 2020, The World Health Organization and UNICEF warned an alarming decline in the number of children receiving life-saving vaccines around the world. This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic. In 2019, UNICEF procured an estimated 2.43 billion doses of vaccines to around 100 countries to reach around 45% of the world’s children below the 5-year-old age group..

Rest of South and Central AmericaTyphoid Fever Vaccines  Market  Revenue and Forecast to 2027 (US$ Mn)

South and Central AmericaTyphoid Fever Vaccines – Market Segmentation

By Vaccine Type

•       Live Attenuated Vaccine
•       Capsular Polysaccharide Vaccines
•       Conjugate Vaccine
•       Others

By Route of Administration

•       Oral
•       Injectable

By Country

•       Brazil
•       Argentina
•       Rest of South and Central America

Company Profiles

•     GlaxoSmithKline plc
•     Shanghai institute of biological products co. ltd.
•     Sanofi
•     Pax Vax Inc
•     BHARAT BIOTECH

South and Central America Typhoid Fever Vaccines Report Scope